ISO 13485 Certification in UAE & Dubai

ISO 13485 certification is an independent third-party conformity assessment of a medical-device quality management system against ISO 13485:2016 within a defined certification scope. The scope identifies the relevant products, processes, services and locations covered by the assessment.

ISO 13485:2016 is the current third edition of the international standard for quality management systems used by organizations involved in medical devices and related services. ISO published this edition in March 2016 and confirmed it as current in 2025.

ISO 13485 is intended for organizations involved in the design, production, installation or servicing of medical devices and related services. It can also be relevant to suppliers and external parties that provide products or quality-management services to medical-device organizations.

ISO 13485 certification is not universally mandatory for every organization in the UAE. Its relevance can depend on the medical device, applicable regulatory pathway, customer expectations, contracts, market-access arrangements and the organization’s role in the supply chain.

ISO 13485 is specifically designed for the medical-device sector and places strong emphasis on regulatory context, product safety, risk management, process validation, traceability and controls across the medical-device life cycle. ISO 9001 is a general quality management standard applicable across sectors.

The system can cover activities such as design and development, purchasing, supplier control, production, installation, servicing, process validation, traceability, monitoring, complaint handling and improvement, depending on the organization’s defined scope and role.

Yes. ISO 13485 can be relevant to organizations that supply products or services to medical-device organizations. The appropriate scope depends on the organization’s activities and the controls it performs within the medical-device supply chain.

A certification programme normally begins with application and scope information, followed by readiness review, Stage 1 and Stage 2 audit activities, a certification decision and ongoing surveillance during the certification cycle. The programme is planned around the organization’s scope, sites, personnel, processes and readiness.

Stage 1 reviews information about the quality management system, scope, locations, processes, documented information and readiness for the Stage 2 certification audit. It helps establish whether the organization is prepared for the next stage.

Stage 2 evaluates whether the medical-device quality management system is implemented and effective within the agreed scope. Auditors use objective evidence from processes, records, controls and operational activities.

There is no single timeline for every organization. Duration depends on scope, number of sites, personnel, product and process complexity, outsourced activities, regulatory context and the maturity of the quality management system.

Management-system certification operates through a defined certification cycle with ongoing surveillance and other applicable audit activities. The organization must continue operating and maintaining its quality management system throughout the cycle.

Evidence can include device and product information, design records where applicable, supplier controls, purchasing records, production records, validation evidence, traceability records, competence records, monitoring data, complaints, corrective actions, internal audits and management review.

Risk management is an important part of the medical-device quality management approach. The organization should establish controls appropriate to its products, processes and regulatory context, with risk considerations reflected across relevant stages of the device life cycle.

For organizations within the relevant scope, ISO 13485 includes controls associated with feedback and complaint handling and supports processes connected with monitoring medical-device performance after release. The exact activities depend on the organization’s role and scope.

ISO 13485 can support market-access activities by providing an internationally recognized quality management framework for medical-device organizations. It does not by itself constitute product registration, market authorization or regulatory approval in a particular country.

Yes. ISO 13485 can be applied by organizations of different sizes. The quality management system should reflect the organization’s products, processes, regulatory context, resources, outsourced activities and defined certification scope.

ISO 13485 can be applied across Dubai, Abu Dhabi, Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain. The certification scope is based on the organization’s medical-device activities, sites, processes and services rather than the emirate alone.

Useful information includes the organization’s medical-device activities, products or services, intended scope, locations, personnel, design or production activities, installation or servicing activities, outsourced processes and existing management-system certification.

No. ISO develops and publishes the standard but does not perform certification. Organizations seeking certification engage an external certification body.